CALGARY, AB / ACCESSWIRE / August 20, 2020 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital" or "Sparta") has entered into an agreement with dynaCERT Inc. to distribute their HydraGEN™ Technology to its TruckSuite™ customer base. The HydraGEN™ Technology is a carbon emissions reduction system that improves the operational efficiency of internal combustion engines.

The Dealer Agreement was put in place to complement the exclusive, symbiotic suite of COVID-19 safety tools that Sparta's TruckSuite Canada™ division has been assembling, as previously announced in a July 16, 2020 news release.

How HydraGEN™ works…

The patented HydraGEN™ technology creates hydrogen on-demand through a unique electrolysis system that supplies gases through the air intake of an internal combustion engine ("ICE") thus enhancing operational efficiency. The result… lower carbon emissions and improved fuel economy. Sparta has been following dynaCERT's distribution progress, including expanding their reach into the United States, as well as Europe, and most recently, their announcement for achieving the acclaimed United Nations Smart City status. While based in Toronto, dynaCERT has a growing national and international reputation as a dynamic energy company.

As previously announced, the suite of COVID-19 safety tools will be branded through the company's TruckSuite™ division, which was originally designed to look after the health of trucks, but has been extended to the health of truckers as well, due to the unusual times we are living in. On July 23, 2020 Sparta issued a news release announcing a licensing agreement to distribute and co-develop a package of nanotechnology formulations aimed at killing harmful pathogens on the drivers and in their cabs, then on August 7, 2020 Sparta issued another news release announcing the signing of a distribution agreement with SBL Testing Technologies to provide fast COVID-19 antibody testing and analysis for truckers [who are putting their lives at risk every day]. Now with the addition of the HydraGen™ technology, it is expected that all the offered benefits will be provided with little or no additional operational cost.

"We're pleased to secure this agreement with dynaCERT so this promising technology can be made available to our client base. It's vitally important for us to continue to add to our environmental technology arsenal to further help our customers lower their carbon footprint and find energy efficiencies. In essence, TruckSuite™ with all its available components, including the HydraGEN™ is about health – health of the vehicle, health of the driver, health of the planet and health of the bottom line for operators," said Sparta President and CTO, John O'Bireck.

Jim Payne, CEO of dynaCERT stated, "The COVID-19 imperative to provide testing and health product to truckers in North America is fully supported by dynaCERT. As Sparta markets such high-profile COVID-19 products to trucking fleets, we are pleased that our patented HydraGEN™ Technology will be featured side by side for this huge market. Clean safe air, inside and outside the cab of every truck, is excellent co-branding for both dynaCERT and Sparta."

At the heart of the TruckSuite™ Canada package is a very powerful bi-directional TreeFrog™ data processing system that allows TruckSuite™ to communicate in real-time with the inter-workings of every vehicle in the network on a 24/7 basis, including with the HydraGEN™. The data gathering, in combination with various industry tools, enables TruckSuite™ to help significantly reduce the Owner/Operator's costly vehicle downtime – and maximize valuable vehicle uptime. Successful participation in the TruckSuite™ program means the vehicle operator can – Just Drive.

About dynaCERT Inc.

dynaCERT Inc. manufactures and distributes Carbon Emission Reduction Technology for use with internal combustion engines. As part of the growing global hydrogen economy, dynaCERT's patented technology creates hydrogen and oxygen on-demand through a unique electrolysis system and supplies these gases through the air intake to enhance combustion, resulting in lower carbon emissions and greater fuel efficiency. The technology is designed for use with many types and sizes of diesel engines used in on-road vehicles, reefer trailers, off-road construction, power generation, mining and forestry equipment, marine vessels and railroad locomotives. Website: www.dynaCERT.com.

About Sparta

Sparta Group (a.k.a. Sparta Capital Ltd.) is a technology-based company that owns or holds a controlling interest in a network of independent businesses that supply energy saving technologies designed to reduce energy inefficiencies, achieve reduced emissions and increase operating efficiencies in various industries. In response to the COVID-19 crisis, Sparta has also expanded its scope to help facilitate supply of necessary materials while assisting talented inventors who are looking to introduce innovative technical solutions that will bring greater normalcy to the post COVID-19 world. Sparta's network of independent businesses provides a wide range of specialized energy capturing, converting, optimizing, and related services to the commercial sector. Sparta provides capital, technical and engineering expertise, legal support, financial and accounting knowledge, strategic planning and other shared services to its independent businesses. Sparta is a publicly traded company listed on the TSX Venture Exchange under the symbol "SAY". Additional information is available on our website at www.spartagroup.ca or on SEDAR at www.sedar.com.

TruckSuite™ Canada is a technology-driven support program that provides fleet Owners/Operators with many of the necessary tools to be competitive in their market. Ltd. As one of the subsidiaries of Sparta Group, TruckSuite™ offers comprehensive maintenance, including roadside emergency assistance; emergency repair with competitive pricing for parts and labour; complete warranty coverage; as well as TripVision®, an integrated vehicle health and safety management system that presents vital information in an easy-to-understand format saving both time and money. TruckSuite™ encourages driver retention between the fleet and independent owner/operator. A secure portal allows fleet Owners/Operators to store any truck-related documents in a safe, easy to access place. For additional information please go to www.trucksuitecanada.ca.

John O'Bireck, President & CTO
Email: jobireck@spartagroup.ca
Telephone: (905) 751-8004

Cautionary Statements:

This news release contains "forward-looking information" within the meaning of applicable securities laws. When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Corporation can give no assurance that they will prove to be correct. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this news release and the Corporation undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Corporation undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Corporation. In particular, this news release contains forward-looking statements relating to, among other things, statements pertaining to the agreement and relationship between Illumineris and Sensor Suite, including but not limited to development of the integrated platform, and actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the failure to obtain necessary regulatory approvals, necessary financing and risks associated with the environmental technologies industry in general. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release).

SOURCE: Sparta Group

ReleaseID: 602546

VANCOUVER, BC / ACCESSWIRE / August 20, 2020 / Black Tusk Resources Inc. ("Black Tusk" or the "Company) (CSE:TUSK)(OTC PINK:BTKRF)(Frankfurt:0NB) is pleased to announce that the company's exploration team are in the process of developing primary drill targets on their 100-per-cent-owned McKenzie East Gold Project, located near Val d'Or, Quebec. The targets will be tested by diamond drilling.

The Phase 1 drilling program will consist of a minimum 1,000-metres of diamond drilling, with the initial 5 drill holes targeting depths between 200 to 300 metres downhole. Phase 1 is designed to test the mineralization potential of several gold targets that occur within the northwestern section of the 1,676-hectare property.

The company has acquired a permit that allows for the construction of 18 drill pads spread over the property. The phase one drill program is expandable as the company continues to review data for additional targets for testing if the decision is made to increase the drilling meterage.

"A 1,000-meter diamond drill program is an excellent start to our goal of conducting multiple drill programs at McKenzie East in 2020. The success of this program, along with continued review of the project database, may define targets that could expand the scope of this initial campaign," states CEO, Richard Penn.

Perry Grunenberg, P.Geo, a "Qualified Person" as that term is defined under NI 43-101, has reviewed and approved the technical information contained in this news release. Mr. Grunenberg is also a Director of the Company.

About Black Tusk Resources Inc.

Black Tusk Resources is a gold-focused Canadian exploration company with operations primarily based in the world-class Abitibi greenstone belt region of Quebec. Black Tusk currently holds 100-per-cent ownership in six separate gold and platinum/palladium properties in Canada

Cautionary Statement

This press release contains forward-looking statements based on assumptions as of that date. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to exploration and development; the ability of the Company to obtain additional financing; the Company's limited operating history; the need to comply with environmental and governmental regulations; fluctuations in the prices of commodities; operating hazards and risks; competition and other risks and uncertainties, including those described in the Company's Prospectus dated September 8, 2017 available on www.sedar.com. Accordingly, actual and future events, conditions, and results may differ materially from the estimates, beliefs, intentions, and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

On behalf of the Board of Directors

Richard Penn
CEO
(778) 384-8923

SOURCE: Black Tusk Resources Inc

ReleaseID: 602528

LOS ANGELES, CA / ACCESSWIRE / August 20, 2020 / LifeQuest World Corp (OTCQB:LQWC), today announced that it will be presenting at the LD 500 Virtual Conference on Wednesday, September 2nd at 1:00 PM PDT / 4:00 PM EDT. Max Khan, president & chief executive officer of LifeQuest, will be presenting to a live audience.

LifeQuest's mission is to become a global leader in low-cost, low-maintenance, eco-friendly, decentralized wastewater treatment. Biopipe, a wholly owned subsidiary, has developed a patented 100% sludge-free, chemical-free, odor-free, silent, easy to assemble and install, scalable, low cost, ecological and virtually maintenance-free onsite sewage wastewater treatment system. With its small footprint and scalability, Biopipe can be installed wherever wastewater is generated, regardless of size and capacity.

Recently announced company milestones include the following:

Signed a definitive agreement with Hydros Agritech, Inc., a consulting and wastewater engineering firm located in California, to create a joint venture that will market Biopipe in North America, Caribbean and U.S. territories.
Signed a Memorandum of Understanding (MOU) with the Water Development Commission of the Ministry of Water, Irrigation and Energy of the Republic of Ethiopia. Pursuant to the MoU, Biopipe will supply a 15m3(3,962 gallon/day) plant (STP), which will be installed at one of the Commission's buildings and is expected to serve as a reference site for all decentralized sewage wastewater projects.
Shipped its first plant to California with a capacity of 10m3/day (2,640 gallons/day). The plant is being installed at a campground in Southern California.
Shipped two plants to Bangladesh. A 75m 3/day plant is for one of Bangladesh's largest industrial groups and a 275m 3/day plant is for a government project.

For additional information about LifeQuest, please visit the company's website at www.lifequestcorp.com

The LD 500 will take place on September 1st through the 4th.

Register here: https://ld-micro-conference.events.issuerdirect.com/

"We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space," stated Chris Lahiji, Founder of LD.

View LifeQuest's profile here: http://www.ldmicro.com/profile/LQWC

Profiles powered by LD Micro – News Compliments of Accesswire

About LifeQuest & Biopipe

LifeQuest offers both effluent treatment (ETP) and sewage treatment (STP) solutions. Biopipe, a wholly owned subsidiary, has developed a patented 100% sludge-free, chemical-free, odor-free, silent, easy to assemble and install, scalable, low cost, ecological and virtually maintenance-free onsite sewage wastewater treatment system. It treats both grey and black water. The treated water exceeds EU and all local standards for discharge and can be reused for irrigation, flushing and cleaning.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

For more information contact:

LifeQuest Investor Relations

TraDigital Marketing Group, Inc.
MJ Clyburn
+1-917-327-684
clyburn@tradigitalir.com

Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

This press release contains forward-looking statements that reflect the Company's current beliefs, expectations or intentions regarding future events. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as "will," "will be," "anticipate," "predict," "expect" "continue," "future," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of the Company and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to: future revenues, expenditures, capital, the adequacy of the Company's current cash and working capital to fund present and planned operations, and the growth through joint ventures. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, can be found in our current Disclosure Statements at www.otcmarkets.com. The Company anticipates that subsequent events and developments may cause views and expectations to change. The Company assumes no obligation, and specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE: LifeQuest World Corp. via LD Micro

ReleaseID: 602243

VANCOUVER, BC / ACCESSWIRE / August 20, 2020 / Skeena Resources Limited (TSX:SKE)(OTCQX:SKREF) ("Skeena" or the "Company") is pleased to announce that it has received final approval to list the Company's common shares on the Toronto Stock Exchange ("TSX"), following its graduation from the TSX Venture Exchange.

The Company's common shares will begin trading on the TSX at the market opening, today, August 20, 2020. To ensure continued and seamless trading for the Company's shareholders and as a result of the graduation, there will be no further trading of Skeena's shares on the TSX Venture Exchange after Wednesday August 19, 2020. Skeena's common shares will be delisted from the TSX Venture Exchange at the commencement of trading on the TSX. The trading symbol for the common shares of Skeena on the TSX will remain unchanged as SKE. The Company's common shares will continue to be listed in the USA on the OTCQX under the symbol SKREF.

Skeena believes that a TSX listing is a consistent next step in the Company's growth, which should facilitate access to a broader range of investors as well as provide exposure to larger pools of capital, including long-term institutional investors and large investors abroad.

Walter Coles Jr., President & CEO commented, "Skeena's graduation to the TSX senior exchange is a natural evolution in the growth of the Company. We've demonstrated a very robust project at Eskay Creek while at the same time have managed to sign a deal to acquire 100% ownership of the mine. We currently have six drills turning at Eskay with more on the way. Assay results are expected shortly. The timing to improve our access to capital markets with the new TSX listing could not be better."

About Skeena

Skeena Resources Limited is a junior mining company focused on developing prospective precious metal properties in the Golden Triangle of northwest British Columbia, Canada. The Company's flagship project is the Eskay Creek gold-silver mine. Skeena is also exploring the past-producing Snip gold mine.

On behalf of the Board of Directors of Skeena Resources Limited,

Walter Coles Jr.
President & CEO

Cautionary note regarding forward-looking statements

Certain statements made and information contained herein may constitute "forward looking information" and "forward looking statements" within the meaning of applicable Canadian and United States securities legislation. These statements and information are based on facts currently available to the Company and there is no assurance that actual results will meet management's expectations. Forward-looking statements and information may be identified by such terms as "anticipates", "believes", "targets", "estimates", "plans", "expects", "may", "will", "could" or "would". Forward-looking statements and information contained herein are based on certain factors and assumptions regarding, among other things, the estimation of mineral resources and reserves, the realization of resource and reserve estimates, metal prices, taxation, the estimation, timing and amount of future exploration and development, capital and operating costs, the availability of financing, the receipt of regulatory approvals, environmental risks, title disputes and other matters. While the Company considers its assumptions to be reasonable as of the date hereof, forward-looking statements and information are not guarantees of future performance and readers should not place undue importance on such statements as actual events and results may differ materially from those described herein. The Company does not undertake to update any forward-looking statements or information except as may be required by applicable securities laws.

Neither TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

CONTACT:

Walt Coles Jr.,
President & CEO
Kelly Earle, Vice President Communications
Email: kearle@skeenaresources.com
Tel: (604) 684-8725

SOURCE: Skeena Resources Limited

ReleaseID: 602500

LOS ANGELES, CA / ACCESSWIRE / August 20, 2020 / GT Biopharma, Inc. (OTCQB:GTBP) (GTBP.PA) (the "Company" or "GT Biopharma") a company focused on developing innovative therapeutic treatments based on its proprietary NK cell engager (TriKE™) platform announced today an update concerning the development of its TriKE™ therapeutic for the treatment of COVID-19 infection. The TriKE™ COVID-19 therapeutic is designed to seek out and kill Novel Coronavirus 2019 (2019-nCoV) virus infected cells before the release of additional virus particles from such infected cells. The ability of the TriKE™ therapeutic to direct the immune system's Natural Killer (NK) cells to target and eliminate distressed cells is a key part of the therapeutic strategy.

GT Biopharma and Cytovance® Biologics, a USA-based contract development and manufacturing company and a member of the Shenzhen Hepalink Pharmaceutical Group of companies, have entered into a collaboration agreement whereby Cytovance is providing drug development services to assist the GT Biopharma with itss TriKE™ therapeutic for the treatment of COVID-19 infection.

Severe acute respiratory syndrome-associated coronavirus infection produces devastating viral pneumonia. Pathologic changes are most prominent in the lungs, with disruptions of the pulmonary epithelial cells in gas exchange areas and conducting airways. It has been reported that the angiotensin converting enzyme 2 (ACE2) receptor is the main host cell receptor targeted by the 2019-nCoV virus, and plays a crucial role in the entry of virus into the cell.

Mr. Anthony Cataldo, the Chairman and Chief Executive Officer of GT Biopharma commented "development is continuing according to plan, and we are working to prepare TriKE™ COVID-19 for further preclinical testing and GMP manufacturing." Mr. Cataldo also stated "we are pleased with the progress Cytovance is making, and are looking forward to being able to evaluate the TriKE™ COVID-19 therapeutic in humans."

About GT Biopharma, Inc.
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology and infectious disease therapeutic products based our proprietary Tri-specific Killer Engager (TriKE™) platform. Our TriKE™ platform is designed to harness and enhance the cancer cell and virus infected cell killing using the patient's immune system NK cells. GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using proprietary TriKE™ technology developed by researchers at the university to target NK cells.

About GTB-3550 TriKE™ FDA Clinical Trial
GTB-3550 is the Company's first TriKE™ product candidate being initially developed for the treatment of acute myeloid leukemia (AML). GTB-3550 is a tri-specific recombinant fusion protein conjugate composed of the variable regions of the heavy and light chains of anti-CD16 and anti-CD33 antibodies and a modified form of IL-15. The NK cell stimulating cytokine human IL-15 portion of the molecule provides a self-sustaining signal that activates NK cells and enhances their ability to kill. We are presently evaluating GTB-3550 in a Phase I/II clinical trial (ClinicalTrials.gov NCT03214666) for the treatment of CD33 positive leukemias such as AML, myelodysplastic syndrome and other CD33+ hematopoietic malignancies.

Forward-Looking Statements
This press release contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that are difficult to predict, including statements regarding the Company's expectations regarding the development of TriKE™ COVID-19, including its intended therapeutic effect, and plans to conduct future clinical trials in humans. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "outlook", "believes", "target", "hopes", "intends", "estimates", "expects", "projects", "plans", "anticipates" and variations thereof, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Our forward-looking statements are not a guarantee of performance and actual results could differ materially from those contained in or expressed by such statements. In evaluating all such statements, we urge you to specifically consider the various risk factors identified in our Form 10-K for the fiscal year ended December 31, 2019 in the section titled "Risk Factors" in Part I, Item 1A and in our subsequent filings with the Securities and Exchange Commission, any of which could cause actual results to differ materially from those indicated by our forward-looking statements.

Our forward-looking statements reflect our current views with respect to future events and are based on currently available financial, economic, scientific, and competitive data and information on current business plans. You should not place undue reliance on our forward-looking statements, which are subject to risks and uncertainties relating to, among other things: (i) the sufficiency of our cash position and our ongoing ability to raise additional capital to fund our operations, (ii) our ability to complete our contemplated clinical trials for any of our drug product candidates, or to meet the FDA's requirements with respect to safety and efficacy, (iii) our ability to identify patients to enroll in our clinical trials in a timely fashion, (iv) our ability to achieve approval of a marketable product, (v) design, implementation and conduct of clinical trials, (vii) the results of our clinical trials, including the possibility of unfavorable clinical trial results, (vii) the market for, and marketability of, any product that is approved, (viii) the existence or development of treatments that are viewed by medical professionals or patients as superior to our products, (ix) regulatory initiatives, compliance with governmental regulations and the regulatory approval process, and social conditions, and (x) various other matters, many of which are beyond our control. Should one or more of these risks or uncertainties develop, or should underlying assumptions prove to be incorrect, actual results may vary materially and adversely from those anticipated, believed, estimated, or otherwise indicated by our forward-looking statements.

Except as required by law, we do not undertake any responsibility to update these forward-looking statements to take into account events or circumstances that occur after the date of this press release. Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by these forward-looking statements.

For more information, please visit www.gtbiopharma.com.

CONTACT:
Media Contact
800-304-9888

SOURCE: GT Biopharma, Inc.

ReleaseID: 602518

Company to discuss growth in SaaS revenues, launch of verbLIVE, and other product initiatives

LOS ANGELES, CA / ACCESSWIRE / August 20, 2020 / VERB Technology Company, Inc. (NASDAQ:VERB) ("VERB" or the "Company"), a leader in interactive video-based sales enablement applications, including interactive livestream ecommerce, webinar, CRM, and marketing applications for entrepreneurs and enterprises, today announced that it will be presenting at the 12th Annual LD 500 Conference on Thursday, September 3, 2020 at 10:00 AM ET. VERB CEO Rory J. Cutaia will present virtually to an online audience.

Mr. Cutaia will provide an overview of the Company, including the launch of verbLIVE, the Company's new interactive, video-based livestream ecommerce and webinar platform, as well as other product initiatives.

Register here: https://ld-micro-conference.events.issuerdirect.com/

Webcast link: https://www.webcaster4.com/Webcast/Page/2019/36208

"We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space," stated Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View VERB Technology Company's profile here: http://www.ldmicro.com/profile/VERB

Profiles powered by LD Micro – News Compliments of Accesswire

About VERB

VERB Technology Company, Inc. (Nasdaq: VERB) transforms how businesses attract and engage customers. The Company's Software-as-a-Service, or SaaS, platform is based on its proprietary interactive video technology, and comprises a suite of sales enablement business software products offered on a subscription basis. Its software applications are available in over 60 countries and in more than 48 languages to large enterprise and small business sales teams that need affordable, easy-to-use, and quick-to-get-results sales tools. Available in both mobile and desktop versions, the applications are offered as a fully integrated suite, as well as on a standalone basis and include verbCRM (Customer Relationship Management application), verbLEARN (Learning Management System application), and verbLIVE (Interactive Livestream eCommerce and Video Webinar application). The Company has offices in California and Utah. For more information, please visit: www.verb.tech.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contacts:

Investor Relations:
888.504.9929
investors@verb.tech

Media Contact:
855.250.2300, ext.107
info@verb.tech

SOURCE: VERB Technology Company, Inc. via LD Micro

ReleaseID: 602543

Company to discuss new patents, partnerships, and supply agreements for its thermal management technologies

LOS ANGELES, CA / ACCESSWIRE / August 20, 2020 / KULR Technology Group, Inc. (OTCQB:KULR) (the "Company" or "KULR"), a leading developer of thermal management technologies for batteries and electronics, announced today that it will be presenting at the 12th Annual LD 500 Conference on Wednesday, September 2, 2020 at 4:20 PM ET. Michael Mo, CEO of KULR, will present virtually to an online audience.

Michael Mo will provide an overview of the Company and discuss key milestones including being recently awarded a patent for its Thermal Runaway Shield (TRS), a passive propagation resistant solution designed and successfully tested to reduce the hazardous risks associated with thermal runaway in lithium-ion battery packs. It was also awarded

a patent on its Fiber Thermal Interface (FTI), a highly flexible and compressible high performance thermally conductive carbon fiber material developed for a variety of different applications, including the space, automotive and electronics industries, as well as for industrial applications.

Register here: https://ld-micro-conference.events.issuerdirect.com/

Webcast link: https://www.webcaster4.com/Webcast/Page/2019/36694

"We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space," stated Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View KULR Technology Group's profile here: http://www.ldmicro.com/profile/KULR

Profiles powered by LD Micro – News Compliments of Accesswire

About KULR Technology Group, Inc.

KULR Technology Group, Inc. develops, manufactures and licenses next-generation carbon fiber thermal management technologies for batteries and electronic systems. Leveraging the company's roots in developing breakthrough cooling solutions for NASA space missions and backed by a strong intellectual property portfolio, KULR enables leading aerospace, electronics, energy storage, 5G infrastructure, and electric vehicle manufacturers to make their products cooler, lighter and safer for the consumer. For more information, please visit www.kulrtechnology.com.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contacts:

Investor Relations:
Keith Pinder
Landon Capital
Main: (404) 995-6671
kpinder@landoncapital.net

Media Contact:
Derek Newton
Head, Media Relations
Main: (786) 499-8998
derek.newton@kulrtechnology.com

SOURCE: KULR Technology Group, Inc. via LD Micro

ReleaseID: 602475

VANCOUVER, BC / ACCESSWIRE / August 20, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1:GR)(OTCQB:PEMTF) (the "Company" or "Thoughtful Brands") is pleased to announce the completion of its acquisition of Golden Path LLC ("Golden Path") and Wild Mariposa LLC ("Wild Mariposa"). Golden Path and Wild Mariposa are privately held fast-growth, direct-to-consumer eCommerce brands selling natural health products in the United States.

The acquisitions will expand Thoughtful Brands' portfolio in the nutraceutical and hemp-based CBD product space. The Company already has a roster of established and successful hemp-CBD brands including Nature's Exclusive in North America and Sativida in Spain and Mexico. Golden Path and Wild Mariposa products are all carefully crafted based on market demand and product quality. Every product is also third-party tested for purity and manufactured in the United States in GMP certified facilities.

Golden Path and Wild Mariposa are current clients of Unified Funding, LLC ("Unified") which performs a number of eCommerce operations for Thoughtful Brands. In June, the Company entered into a binding term sheet to acquire the Unified eCommerce platform, signifying another key strategic growth initiative. This allows Thoughtful Brands to continue to grow its health products business more rapidly on an international scale, tapping into entering new natural health markets and developing new products.

"Thanks to our relationship with Unified, our eCommerce and technology abilities are first rate. These brands not only complement our existing natural health product lines but position us for continued growth and advance our Company as a leader in the space," said Ryan Hoggan, CEO of Thoughtful Brands. "An increased focus on consumer brands and expanding our market footprint constitute our core strategies and growth trajectory at Thoughtful Brands. These two acquisitions come on the heels of several strategic acquisitions which are key to our larger goal to reach new customers internationally and increase eCommerce capabilities."

Among other recent accomplishments, Thoughtful Brands recently announced a European expansion through a joint venture with Franchise Cannabis Corp. Through this partnership, Thoughtful Brands will sell and market Franchise-manufactured CBD, hemp and cosmetic products in the European Union, Switzerland, Norway and the UK, utilizing its well-established eCommerce platform.

Acquisition Details

The Company has acquired Golden Path and Wild Mariposa pursuant to purchase agreements entered into with the respect members of Golden Path and Wild Mariposa, dated effective August 19, 2020. In consideration for acquisition of all of the outstanding membership interests in Golden Path and Wild Mariposa the Company has issued 11,544,400 common shares and 15,055,600 common shares (collectively, the "Consideration Shares"), respectively. The Consideration Shares were issued to the existing members of Golden Path and Wild Mariposa at a deemed price of Cdn$0.195 per share.

The Company is at arms-length from each of Golden Path, Wild Mariposa and their respective members. The transactions do not constitute a fundamental change for the Company, and have not resulted in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. The Company has paid an administrative fee of 266,000 common shares of the Company to a consultant who assisted with the transactions.

About Thoughtful Brands Inc.

Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

ON BEHALF OF THE BOARD OF DIRECTORS

THOUGHTFUL BRANDS INC.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at info@thoughtful-brands.com or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including with respect to its plans to acquire additional revenue-producing natural health product brands and operations in both Europe and North America with the goal of establishing an international distribution network utilizing its eCommerce technology platform. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Thoughtful Brands Inc.

ReleaseID: 602533

Leading players in the encoder market remain largely invested in research for product improvements, to widen scope of application in multiple verticals.

DUBAI, UAE / ACCESSWIRE / August 20, 2020 / The encoders market is anticipated to show a healthy 7.5% CAGR during the assessment period from 2020 to 2030. The covid-19 pandemic has substantially hurt short term growth prospects of the encoder industry. Strict nationwide lockdowns imposed by governments to contain the spread of the outbreak has severely curtailed industrial activities in multiple sectors including material handling, aerospace, textile, and manufacturing. This will reduce demand for encoders in the near future.

"Rising demand for automation in industrial settings, coupled with the deployment of Industry 4.0 practices. The market is anticipated to witness robust growth during the period of assessment owing to increasing popularity of digitized equipment, which previously operated on analog settings," says the FMI report.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7696

Encoders – Primary Takeaways

Incremental rotary encoders are finding increased demand, particularly in the automotive sector, driven by application of electronic position sensing devices in fabrication and assembly processes.
Niche applications in consumer electronics and logistics sector are gaining ground on account for smart device, IoT and internet penetration.
Asia Pacific is witnessing rapid growth in encoder deployment supported by major investments in robotic installations in industry 4.0 facilities, in China, South Korea, India, and Japan.

Encoders – Growth Factors

New applications in the printing and textiles industries in motor feedback and web tensioning processes will prove lucrative to market players.
The growing trend of digitization of analog devices in industry 4.0 settings provides impetus to market growth.

Encoders – Major Constraints

High complexity of manufacturing encoders restrains development of new technology and limits market growth.
Presence of delicate components and limited range of operable temperature restrict encoder applications.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-7696

The Projected Impact of Coronavirus

The coronavirus pandemic has significantly curtailed the overall global economy, which in turn has also hurt technology supply chains. Falling business confidence in multiple industrial verticals, and the slump in manufacturing processes including industries of automotive, aerospace, and consumer goods during lockdowns in various countries has reduced the demand for encoder technologies and devices. Applications in the food & beverage, and packaging industries will help to reduce losses during this period. The market is likely to display strong recovery to pre-pandemic levels towards 2021.

Competition Landscape

The encoders market comprises players including but not limited to TE Connectivity, OMRON Corp., Fraba B.V., Baumer Electric AG, Dynapar, Schneider Electric, Rockwell Automation Inc., Panasonic Corp., Honeywell International Inc., and Renishaw plc.

Participants in the encoders market are pushing for product development and launch strategies to meet growing demand in regional markets, also aiding geographical and industrial penetration.

For instance, NORD Drivesystems has developed a multi-encoder interface for muti-axis operations of inverters. Heidenhain has unveiled a range of functionally safety rated linear and absolute angle encoders. SICK has released new absolute encoders which operate on IO-Link principles for higher fieldbus integration.

Request Special Price for this Report to our Sales Executive@ https://www.futuremarketinsights.com/request-special-price/rep-gb-7696

More About the Study

The FMI study provides detailed insights on encoders. The market is broken down in terms of type (linear and rotary), position signal (absolute and incremental), sensing technology (optical, magnetic, capacitive, and inductive) and application (automotive, consumer electronics, aerospace & defense, healthcare & medical devices, industrial, and others), across six key regions (North America, Latin America, Europe, East Asia, South Asia & Pacific, and MEA).

Explore Future Market Insights Coverage of the Electronics, Semiconductors & ICT Industry

Flat Panel Display Market: Find insights on the flat panel display market with segment analysis, statistics, influencing factors, players and key strategies adopted by market players for a 10-year forecast period.

Residential Robotic Vacuum Cleaner Market: FMI's report on the residential robotic vacuum cleaner market offers details on the market between 2016 -2021. The study covers influencers, revenue sources, market leaders, and strategies.

Advanced Distribution Management Systems Market: Get an in-depth analysis on the advanced distribution management systems market with insights on growth levers, opportunities, policies, restraints, regional markets and market leaders.

About Future Market Insights

Expert analysis, actionable insights, and strategic recommendations of the experienced research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of more than thousand reports and 1 million+ data points, the team has studied the electronics, semiconductors, and ICT sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/encoder-market
Press Release Source: https://www.futuremarketinsights.com/press-release/encoder-market

SOURCE: Future Market Insights

ReleaseID: 602570

OLD BRIDGE, NJ / ACCESSWIRE / August 20, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) commented today on its continuing efforts to reduce its costs and conserve its working capital and liquidity. While the Company has indicated that there have been no material developments or change in circumstances with respect to the Company's ongoing business activities since the Company issued its second quarter earnings release on August 7, 2020, the Company is providing this additional commentary to confirm its continuing evaluation of cost and overhead reduction programs and reiterate certain previously-disclosed working capital conservation efforts that began in late 2019.

Blonder Tongue's Chief Executive Officer Ted Grauch noted, "Beginning in the third quarter of 2019, Blonder Tongue began a comprehensive program to reduce operational costs, and those efforts have continued throughout 2020, and have been adapted in light of the effects of the COVID-19 pandemic on our business. As previously disclosed, we are continuing to evaluate and implement further cost and overhead reduction programs to address a potential extended period of reduced economic activity, including the possibility of these conditions continuing through at least the end of the year. In furtherance of these initiatives, through voluntary deferred compensation arrangements with our executive management team and certain directors, we have reduced our cash compensation outlays for 2020."

As previously disclosed, the Company and its executive management team have entered into deferred compensation arrangements through which the officers have agreed to suspend payments of a certain percentage of their cash compensation in exchange for the Company accruing, on each date the cash compensation would otherwise be due, a number of shares of the Company's common stock equal to the cash compensation otherwise payable on such date divided by the fair market value of the common stock on such date. The shares accrued on behalf of each of the executives will be delivered to each of them on or before certain dates in 2021. In addition, certain of the Company's directors have similarly agreed to defer all or a portion of their cash directors' fees in return for the Company accruing shares of its common stock on substantially similar terms, and two of the Company's directors have agreed to defer 100% of their cash directors fees that would otherwise be payable in 2020, in return for the payment of such deferred amounts in cash over a five-month period commencing in January 2021.

As circumstances warrant, the Company may enter into additional deferred compensation arrangements with its officers, directors and other key staff, based on and as economic circumstances dictate. The implementation of the foregoing equity-based deferred compensation arrangements as they relate to certain persons, including the Company's executive officers and the Company's directors, require periodic filings with the Securities and Exchange Commission pursuant to Section 16 of the Securities Exchange Act of 1934 on Form 4, disclosing the acquisition and divestiture of shares of the Company's common stock.

About Blonder Tongue
Blonder Tongue Laboratories, Inc. is the oldest designer and manufacturer of cable television video transmission technology in the USA. The majority of our products continue to be designed and built in our state-of-the-art New Jersey facility, which has been the Company's home for more than 50 years. Blonder Tongue Labs offers U.S.-based engineering and manufacturing excellence with an industry reputation for delivering ultra-high reliability products. As a leader in cable television system design, the Company provides service operators and systems integrators with comprehensive solutions for the management and distribution of digital video, IPTV and high-speed data services, as well as RF broadband distribution over fiber, IP, and Coax networks for homes and businesses. Additional information on the Company and its products can be found at www.blondertongue.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:The information set forth above includes "forward-looking" statements and accordingly, the cautionary statements contained in Blonder Tongue's Annual Report and Form 10-K for the year ended December 31, 2019 (See Item 1: Business, Item 1A: Risk Factors, Item 3: Legal Proceedings and Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations), and other filings with the Securities and Exchange Commission are incorporated herein by reference. The words "believe", "expect", "anticipate", "project", "target", "intend", "plan", "seek", "estimate", "endeavor", "should", "could", "may" and similar expressions are intended to identify forward-looking statements. In addition, any statements that refer to projections for our future financial performance, our anticipated growth trends in our business and other characterizations of future events or circumstances are forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. Blonder Tongue undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Blonder Tongue's actual results may differ from the anticipated results or other expectations expressed in Blonder Tongue's "forward-looking" statements.

CONTACTS:
Eric Skolnik
Chief Financial Officer
eskolnik@blondertongue.com
(732) 679-4000

Ted Grauch
Chief Executive Officer
tgrauch@blondertongue.com
(732) 679-4000

SOURCE: Blonder Tongue Laboratories, Inc.

ReleaseID: 602511